Form 8-K - Current report:
SEC Accession No. 0001104659-24-128984
Filing Date
2024-12-16
Accepted
2024-12-16 17:15:26
Documents
13
Period of Report
2024-12-10
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2431088d1_8k.htm   iXBRL 8-K 26261
  Complete submission text file 0001104659-24-128984.txt   202131

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20241210.xsd EX-101.SCH 3027
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20241210_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20241210_pre.xml EX-101.PRE 22367
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2431088d1_8k_htm.xml XML 3812
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 241552784
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)